AD
Binimetinib(CAS: 606143-89-9)
CAS Number
Related Products
![6-Bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-[(3S)-3-piperidinyl]pyrazolo[1,5-a]pyrimidin-7-amine](https://static.chemtradehub.com/structs/891/891494-64-7-55c2.webp)
![6-(4-Fluorophenyl)-5-(4-pyridinyl)-2,3-dihydroimidazo[2,1-b][1,3]thiazole](https://static.chemtradehub.com/structs/728/72873-74-6-9f65.webp)
![1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone](https://static.chemtradehub.com/structs/844/844903-58-8-626b.webp)
![2,4,6-Trifluoro-N-{6-[(1-methyl-4-piperidinyl)carbonyl]-2-pyridinyl}benzamide hydrochloride (1:1)](https://static.chemtradehub.com/structs/613/613677-28-4-fcb7.webp)
![6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methylnicotinamide](https://static.chemtradehub.com/structs/720/720690-73-3-4448.webp)
![{2-Methyl-1-[4-(methylsulfonyl)-2-(trifluoromethyl)benzyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}acetic acid](https://static.chemtradehub.com/structs/872/872365-14-5-6bf8.webp)
![N-[(2S,3R)-3-Hydroxy-1-(hydroxyamino)-1-oxo-2-butanyl]-4-{[4-(4-morpholinylmethyl)phenyl]ethynyl}benzamide](https://static.chemtradehub.com/structs/728/728865-23-4-3f6c.webp)
Other Suppliers for Binimetinib
Basic Information
Molecular Formula
C17H15BrF2N4O3
Molecular Weight
441.23 g/mol
Physical Properties
Density
1.67
Chemical Identifiers
SMILES
CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO
InChIKey
ACWZRVQXLIRSDF-UHFFFAOYSA-N
Database References
MDL Number
MFCD22124525
FAQ
Binimetinib (CAS: 606143-89-9) falls under several regulatory guidelines. It must comply with REACH in Europe, which requires registration of substances above a certain tonnage. In the United States, it is regulated by the FDA for pharmaceutical uses and EPA for environmental safety. Additionally, it should adhere to GHS classification standards for chemical hazards.
Binimetinib (CAS: 606143-89-9) has several analogs and isomers that can be used in synthesis. Common alternatives include other MEK inhibitors, such as trametinib and cobimetinib. Substitute reagents like different aldehydes or ketones can also be explored, depending on the specific synthetic route.
Binimetinib (CAS: 606143-89-9) is a focus in oncology research, particularly for treating RAS-driven cancers. Market trends indicate increasing demand due to its effectiveness in combination therapies. Research is also exploring new applications and improving its delivery systems to enhance therapeutic outcomes.
Waste containing binimetinib (CAS: 606143-89-9) should be handled with care to comply with environmental regulations. Collect waste liquids in appropriate containers and incinerate or dispose of them through a professional service. Ensure all handling procedures are documented and follow local, state, and federal guidelines for hazardous waste management.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
service@2hpharm.com